Thomas Charles Shad is a seasoned sales executive with many years of experience in the medical diagnostic industry, including an extensive focus on POC PT/INR Monitoring, as well as extensive experience in diabetes healthcare, including continuous glucose monitoring. He has worked with companies such as Roche Diagnostics, Astute Medical, and Horiba Medical, where he contributed to sales growth, recruiting and training as well as the introduction of new and novel healthcare technologies. Thomas Charles Shad's work has included launching products like the CoaguChek PT/INR Monitoring System, several Accu-Check glucose monitoring systems, GIAPREZA, which is an FDA-approved injection that increases blood pressure in adults with septic shock, and NEPHROCHECK, which is used to monitor acute kidney injury. In addition, Tommy also specializes in recruiting, managing, and leading top-performing sales teams in competitive markets.
Throughout his career, Tommy C. Shad has achieved notable milestones, including securing significant contracts and receiving awards for his contributions. At Roche Diagnostics, he worked on strategic collaborations and the promotion of diagnostic tools such as the cobas Liat, an automated instrument used in respiratory illness testing, specifically testing for SARS-CoV-2, Influenza A/B, RSV, group A Strep, and C. Difficile. His expertise spans launching FDA-approved therapies, navigating complex sales environments, and driving revenue.
In his free time, Tommy C. Shad enjoys coaching travel baseball, flying, and cooking. He is also an Atlanta Braves fan!